These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 17072707)
1. The story of Vioxx--no pain and a lot of gain: ethical concerns regarding conduct of the pharmaceutical industry. Cahana A; Mauron A J Anesth; 2006; 20(4):348-51. PubMed ID: 17072707 [No Abstract] [Full Text] [Related]
2. Vioxx doctors wooed by Merck are now its foes. Tesoriero HW Wall St J (East Ed); 2006 Mar; ():B1, B3. PubMed ID: 16578911 [No Abstract] [Full Text] [Related]
3. Evaluating drug effects in the post-Vioxx world: there must be a better way. Avorn J Circulation; 2006 May; 113(18):2173-6. PubMed ID: 16684873 [No Abstract] [Full Text] [Related]
4. Clinical trials in the wake of Vioxx: requiring statistically extreme evidence of benefit to ensure the safety of new drugs. Roth-Cline MD Circulation; 2006 May; 113(18):2253-9. PubMed ID: 16684875 [No Abstract] [Full Text] [Related]
5. Don't blame it all on the bogey. Day M BMJ; 2007 Jun; 334(7606):1250-1. PubMed ID: 17569929 [TBL] [Abstract][Full Text] [Related]
8. Court hears how drug giant Merck tried to "neutralise" and "discredit" doctors critical of Vioxx. Moynihan R BMJ; 2009 Apr; 338():b1432. PubMed ID: 19349350 [No Abstract] [Full Text] [Related]
9. [Really only Vioxx?]. Heinzl S Med Monatsschr Pharm; 2004 Nov; 27(11):361. PubMed ID: 15566229 [No Abstract] [Full Text] [Related]
10. The problem of new uses. Eisenberg RS Yale J Health Policy Law Ethics; 2005; 5(2):717-39. PubMed ID: 16052897 [No Abstract] [Full Text] [Related]
11. Emerging from the shadow of Vioxx. Lindsley CW Curr Top Med Chem; 2007; 7(7):739. PubMed ID: 17450647 [No Abstract] [Full Text] [Related]
12. The NSAID roller coaster: more about rofecoxib. Aronson JK Br J Clin Pharmacol; 2006 Sep; 62(3):257-9. PubMed ID: 16934039 [No Abstract] [Full Text] [Related]
13. Vioxx, the implosion of Merck, and aftershocks at the FDA. Horton R Lancet; 2004 Dec 4-10; 364(9450):1995-6. PubMed ID: 15582041 [No Abstract] [Full Text] [Related]
14. The lessons of Vioxx. Frazier KC N Engl J Med; 2005 Sep; 353(13):1420-1; author reply 1420-1. PubMed ID: 16192497 [No Abstract] [Full Text] [Related]
15. The Vioxx fallout. Palmer K Minn Med; 2005 Mar; 88(3):26-30. PubMed ID: 15852592 [No Abstract] [Full Text] [Related]
19. How the New England Journal missed warning signs on Vioxx: medical weekly waited years to report flaws in article that praised pain drug; Merck seen as "punching bag". Armstrong D Wall St J (East Ed); 2006 May; ():A1, A10. PubMed ID: 16848016 [No Abstract] [Full Text] [Related]
20. A message from the Vioxx case. Baldwin HJ; Droege M; Daniel KL Am J Health Syst Pharm; 2006 Mar; 63(6):503. PubMed ID: 16522877 [No Abstract] [Full Text] [Related] [Next] [New Search]